Insider Transactions in Q1 2024 at Cidara Therapeutics, Inc. (CDTX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2024
|
Taylor Sandison Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
128,750
+21.3%
|
-
|
|
Mar 15
2024
|
Leslie Tari CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
111,250
+23.12%
|
-
|
|
Mar 15
2024
|
Preetam Shah Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
108,750
+24.45%
|
-
|
|
Mar 15
2024
|
Shane Ward COO & CLO |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+27.35%
|
-
|
|
Mar 11
2024
|
Preetam Shah Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
18,931
-7.69%
|
$0
$0.67 P/Share
|
|
Mar 11
2024
|
Shane Ward COO & CLO |
SELL
Open market or private sale
|
Direct |
20,473
-9.34%
|
$0
$0.67 P/Share
|
|
Mar 11
2024
|
Taylor Sandison Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,662
-5.62%
|
$0
$0.67 P/Share
|
|
Mar 11
2024
|
Leslie Tari CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
21,029
-7.52%
|
$0
$0.67 P/Share
|
|
Mar 11
2024
|
Jeffrey Stein President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
56,692
-4.68%
|
$0
$0.69 P/Share
|